Kendall Capital Management

Position in HRMY — Harmony Biosciences Holdings, Inc.

CIK 1731372 ROCKVILLE, MD

Position in HRMY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$261,787

+$46,251 QoQ

Shares Held

7,190

-6.6% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#231

of 328 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kendall Capital Management holds $6,297,958 across 5 Biotechnology names. HRMY ranks #5 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	9,719	$2,341,987
2	INCY	Incyte Corp	12,780	$1,448,740
3	REGN	Regeneron Pharmaceuticals, Inc.	2,196	$1,369,293
4	INVA	Innoviva, Inc.	38,580	$876,151
5	HRMY	Harmony Biosciences Holdings, Inc. This page	7,190	$261,787

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$261,787	7,190	-6.6%	Shares	Sole	2026-08-12
2026-03-31	$215,536	7,695	—	Shares	Sole	2026-04-24
No filing history on record for this holder in this stock.